Palvella Therapeutics, Inc. (PVLA) SEC Filings — 2024

Filings

• Palvella Therapeutics Files S-1 — S-1 · Dec 31, 2024
• Palvella Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Dec 17, 2024
• Palvella Therapeutics, Inc. Renamed, Completes Business Combination — 8-K · Dec 16, 2024
• Pieris Pharmaceuticals Files 8-K with Corporate Updates — 8-K · Dec 12, 2024
• Pieris Pharmaceuticals Files 8-K — 8-K · Dec 3, 2024
• Pieris Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Pieris Pharmaceuticals Q3 2024: Net Loss of $12.5M — 10-Q · Nov 13, 2024
• Pieris Pharmaceuticals Files Definitive Proxy Statement — DEF 14A · Nov 6, 2024
• Pieris Pharmaceuticals Files 8-K — 8-K · Oct 3, 2024
• Pieris Pharma Q2 2024: $0.7M Revenue, $12.5M Cash — 10-Q · Aug 14, 2024
• Pieris Pharmaceuticals Files 8-K: Agreements and Shareholder Rights Changes — 8-K · Aug 8, 2024
• Pieris Pharmaceuticals, Inc. SC 13G Filing — SC 13G · Aug 1, 2024
• Pieris Pharmaceuticals Files 8-K: Agreements, Equity Sales, and Officer Changes — 8-K · Jul 24, 2024
• Pieris Pharmaceuticals Terminates Material Agreement — 8-K · Jul 3, 2024
• Pieris Pharmaceuticals, Inc. SC 13G Filing — SC 13G · May 17, 2024
• Pieris Pharmaceuticals, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 15, 2024
• Seagen to Acquire Pieris Pharmaceuticals for $1.7 Billion — 8-K · May 9, 2024
• Pieris Pharmaceuticals Files 10-K/A Amendment — 10-K/A · Apr 29, 2024
• Pieris Pharmaceuticals Files 8-K with Key Updates — 8-K · Apr 18, 2024
• Pieris Pharmaceuticals, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 29, 2024
• Pieris Pharmaceuticals Files 8-K — 8-K · Mar 27, 2024
• Pieris Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Pieris Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Pieris Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Soleus Capital Amends Pieris Pharma Stake as of Dec 31, 2023 — SC 13G/A · Feb 2, 2024